Updates to our Terms of Use

We are updating our Terms of Use. Please carefully review the updated Terms before proceeding to our website.

Sunday, May 19, 2024 | Back issues
Courthouse News Service Courthouse News Service

Drug Patents

PHILADELPHIA - Cephalon's purported patent for the sleep-disorder drug Provigil is invalid for a host of reasons, including failure to inform patent officials that French drugmaker Laboratoire Lafon was heavily involved in Provigil's development, a federal judge ruled.

Categories / Uncategorized

Subscribe to Closing Arguments

Sign up for new weekly newsletter Closing Arguments to get the latest about ongoing trials, major litigation and hot cases and rulings in courthouses around the U.S. and the world.